Conformationally Locked Carbocyclic Nucleosides
629
3. Schroeder, G.K.; Wolfenden, R. Rates of spontaneous disintegration of DNA and the rate
enhancements produced by DNA glycosylases and deaminases. Biochemistry, 2007, 46, 13638–
13647.
4
5
6
7
. Agarwal, R.P.; Spector, T.; Parks, R.E. Tight-binding inhibitors—IV. Inhibition of adenosine deami-
nases by various inhibitors. Biochem. Pharmacol. 1979, 26, 259–267.
. Glazer, R.I. Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression.
Cancer Chemother. Pharmacol. 1980, 4, 227–235.
. Smyth, J.F.; Prentice, H.G.; Proctor, S.; Hoffbrand, A.V. Deoxycoformycin in the Treatment of
Leukemias and Lymphomasa. Ann. N.Y. Acad. Sci. 1985, 451, 123–128.
. Laliberte, J.; Marquez, V.E.; Momparler, R.L. Potent inhibitors for the deamination of cytosine
ꢁ
arabinoside and 5-aza-2 -deoxycytidine by human cytidine deaminase. Cancer Chemother. Pharmacol.
1992, 30, 7–11.
8
9
. Lemaire, M.; Momparler, L.F.; Bernstein, M.; Marquez, V.E.; Momparler, R.L. Enhancement of
antineoplastica acion of 5-aza-2 -deoxycytidine by zebularine on L1210 leukemia. Anti-Cancer Drugs.
ꢁ
2005, 16, 301–308.
. Wilson, D.K.; Rudolph, F.B.; Quiocho, F.A. Atomic structure of adenosine deaminase complexed
with transition-state analog: understanding catalysis and immunodeficiency mutations. Science 1991,
252, 1278–1284.
1
1
1
1
1
0. Sharff, A.J.; Wilson, D.K.; Chang. Z.; Quiocho, F.A. Refined 2.5 A˚ structure of murine adenosine
deaminase at pH 6.0. J. Mol. Biol. 1992, 226, 917–921.
1. Kinoshita, T.; Nishio, N.; Nakanishi, I.; Sato, A.; Fujii, T. Structure of bovine adenosine deaminase
complexed with 6-hydroxy-1,6-dihydropurine. Acta Cryst. 2003, D59, 299–303.
2. Xiang, S.; Short, S.A.; Wolfenden, R.; Carter, C.W. Jr. Transition-state selectivity for a single hydroxyl
group during catalysis by cytidine deaminase. Biochemistry 1995, 34, 4516–4523.
3. Betts, L.; Xiang, S.; Short, S.A.; Wolfenden, R.; Carter, C.W. Jr. Cytidine deaminase. The 2.3 A˚ crystal
structure of an enzyme:transition-state complex. J. Mol. Biol. 1994, 235, 635–656.
4. According to high level calculations it appears that the zebularine 3,4-hydrate may be unstable and
that proton transfer from the Zn-OH group to Glu-104 in E. coli leads to an alkoxide-like inhibitor
that functions a the real tansition state. Guo, H.; Rao, N.; Xu, Q.; Guo, H. Origin of tight binding of
a near-perfect transition-state analogue by cytidine deaminase: Implications for enzyme catalysis. J.
Am. Chem. Soc. 2005, 127, 3191–3197.
15. Carter, C.W. Jr. The nucleoside deaminases for cytidine and adenosine: structure, transition state
stabilization, mechanism, and evolution. Biochimie 1995, 77, 92–98.
16. Seewach, D.S.; Krawczyk, S.H.; Acevedo, O.L.; Townsend, L.B. Rapid communication: Inhibi-
tion of adenosine deaminase by azapurine ribonucleosides. Biochem. Pharmacol. 1992, 44, 1697–
1700.
1
1
1
7. McCormack, J.J.; Marquez, V.E.; Liu, P.S.; Vistica, D.T.; Driscoll, J.S. Inhibition of cytidine deaminase
by 2-oxopyrimidine riboside and related compounds. Biochem. Pharmacol. 1980, 29, 830–832.
8. Johansson, E.; Mejlhede, N.; Neuhard, J.; Larsen, S. Crystal structure of the tetrameric cytidine
deaminase from Bacillus subtilis at 2.0 A˚ resolution. Biochemistry, 2002, 41, 2563–2570.
9. Teh, A.-H.; Kimura, M.; Yamamoto, M.; Tanaka, N.; Yamaguchi, I.; Kumasaka, T. The 1.48 A˚
resolution crystal structure of the homotetrameric cytidine deaminase from mouse. Biochemistry
2006, 45, 7825–7833.
20. Chung, S.; Fromme, J.C.; Verdine, G.L. Structure of human cytidine deaminasebound to a potent
inhibitor. J. Med. Chem. 2005, 48, 658–660.
2
1. Carlow, D.C.; Carter, C.W. Jr.; Mejlhede, N.; Neuhard, J.; Wolfenden, R. Cytidine deaminase from B.
subtilis and E. coli: Compensating effects of changing zinc coordination and quaternary structure.
Biochemistry 1999, 38, 12258–12265.
22. Wang, Z.; Quiocho, F.A. Complexes of adenosine deaminase with two potent inhibitors: X-ray
structures in four independent molecules at pH of maximum activity. Biochemistry, 1998, 37,
8314–8324.
2
2
4. Kati, W.M.; Acheson, S.A.; Wolfenden, R. A transition state in pieces: Major contributions of entropic
effects to ligand binding by adenosine deaminase. Biochemistry, 1992, 31, 7356–7366.
5. Carlow, D.; Wolfenden, R. Substrate connectivity in the transition state for cytidine deaminase.
Biochemistry 1998, 37, 11873–11878.
2